Related Experiment Video
Updated: May 11, 2026
Microvascular Decompression: Salient Surgical Principles and Technical Nuances
Published on: July 5, 2011
Microvascular decompression: a surgical option for refractory hypertension of neurogenic etiology
Jessica Barley1, Charles Ellis
1Department of Health Sciences and Research, Medical University of South Carolina, Charleston, SC, USA. barley@musc.edu
Insights
Microvascular decompression (MVD) may effectively treat refractory hypertension (RHTN) of neurogenic causes. This surgical intervention shows promise in normalizing blood pressure for patients with difficult-to-treat hypertension.
Area of Science:
- Neurosurgery
- Cardiology
- Hypertension Research
Background:
- Essential hypertension affects a significant US population segment.
- Refractory hypertension (RHTN) is uncontrolled despite multiple antihypertensive agents.
- Neurogenic causes are common in RHTN, often requiring surgical intervention.
Purpose of the Study:
- To review the efficacy of microvascular decompression (MVD) for refractory hypertension of neurogenic causes (RHTN-N).
- To assess MVD as a potential surgical treatment for difficult-to-treat hypertension.
Main Methods:
- Literature review of studies reporting outcomes of MVD in RHTN-N patients.
- Analysis of blood pressure normalization following MVD intervention.
Main Results:
- MVD shows potential for normalizing blood pressure in some RHTN-N patients.
- A subset of patients with RHTN-N experienced improved blood pressure control post-MVD.
Conclusions:
- Microvascular decompression may be an effective surgical option for refractory hypertension of neurogenic origin.
- Further research is needed to solidify MVD's role in treating RHTN-N.
Abstract:
Essential or unexplained hypertension exists in a significant segment of the US population. Among those with essential or unexplained hypertension is a subset of patients who are diagnosed with 'refractory hypertension' (RHTN) or uncontrolled hypertension despite sustained therapy with at least three antihypertensive agents. Neurogenic etiologies are prevalent among patients with RHTN, with a notable proportion requiring surgical intervention to normalize their blood pressure. Microvascular decompression (MVD) has emerged as a surgical intervention that may be efficacious for the treatment of RHTN. A review of studies reporting outcomes associated with MVD as a treatment approach for refractory hypertension of neurogenic causes (RHTN-N) suggests that blood pressure can be normalized after MVD in some patients with RHTN-N. Consequently, additional studies are needed to offer additional evidence to support MVD as an effective surgical intervention for difficult-to-treat patients with RHTN-N.
